Toggle navigation
TWunroll
TWunroll
faq
Contact US
#Immunotherapy
Pashtoon Kasi MD, MS
pashtoonkasi
Another agnostic approval.#Pembrolizumab #TMBTMB cutoff >=Though I’m overall very supportive of agnostic approvals overall, not sure if TMB is the same across tissue types. @US_FDA #OncoAlert #PrecisionMedicine https://seekingalpha.com
Read more
au ng
athein1
RBG update #RBG #RuthBaderGinsburg 1/ As I have been speculating based on the publicly available info, RBG turns out to have been on chemo to treat her advanced pancreatic ca.
Read more
Jesus Ramirez-Bermudez
JRBneuropsiq
1/5 After the 2017 devastating Mexico earthquake, a 37-year-old man, aid volunteer, started to feel “weaker physically and mentally.” He felt fear & guilt because “he couldn’t provide help when
Read more
Amit Kulkarni
AmitKulkarniMD
#FDA recently approved #pembrolizumab- a tissue agnostic indication in metastatic tumors with high #TMB (>10 mut/MB) using Foundation One Dx companion diagnostic test. I want to share a tweetorial on
Read more
Benjamin Vincent
BenjaminGVincen
A on T cell receptor repertoire diversity in cancer RNA-sequencing studies, based on great work by @BortoneDante reported in @CIR_AACR: …https://cancerimmunolres-aacrjournals-org.libproxy.lib.unc.edu/content/9/1/103 (1/n) T cells k
Read more
Eli Van Allen
VanAllenLab
Lately I've found it useful to not only reflect on all we've all lost over the last year, but also consider why - in the spirit of #InaugurationDay -
Read more
Sarah Blagden
sarah_blagden
Some of our cancer patients have been refused COVID vaccines. I thought I'd summarise guidance (taken from UK chemotherapy Board, Thames Valley Haematology and PHE guidelines) that applies to Oxford
Read more
Lorand Kis
kis_lorand
Spindle cell tumor in the dermis. Any thoughts on what it could be? #pathology #IHCpath #dermpath 1. Thanks everyone for engaging!!! Differential diagnosis includes and is not limited to:Benign lesions/tumors-
Read more
Ryan Reeves
investing_city
Genomics Thread #6Let's talk about liquid biopsies... 1/ A liquid biopsy is usually a blood-based test that can detect cancer. How?By detecting either CTC (circulating tumor cells) or ctDNA (circulating
Read more
Tobias Hohl
tmhohl71
1/n The ID service @sloan_kettering reports in @naturemed on determinants of #COVID19 severity in 423 symptomatic cancer patients treated at our institution. What did we find?https://www.nature.com/articles/s41591-020-0979-0 2/n Overall, 40
Read more
UPMC Hillman Cancer Center
UPMCHillmanCC
Happy #WomenInScience Day! To celebrate, we want to highlight some of the female researchers who are pioneering the future of cancer treatment and care at UPMC Hillman and @PittTweet. Meet
Read more
Stephen V Liu
StephenVLiu
#OncoAlert Retrospective report @JTOonline on outcomes with chemoradiation plus durvalumab (PACIFIC) in patients with #EGFR mutant NSCLC. #LCSM https://www.jto.org/article/S1556-0864(21)01702-0/fulltext Cohort of 37 patients with #EGFR muta
Read more
SMangold46804
mangold46804
1/ Happy Thursday! Here is an interesting Pediatric Neurology #MedTweetorial case. A 12 y/o female presents to the office with visual concerns. 3 days ago, her right eye became progressively
Read more
Alex Shoushtari, MD
alexshoushtari
Hi #medtwitter + new onc fellows! I treat patients with advanced #melanoma, especially rare ones like #uvealmelanoma (UM). This #tweetorial will discuss:1) Why UM is unique 2) When does(n’t) immunotherapy
Read more
Liz Johnson
wired4story
The past 8 years has seen a lot of targeted therapies for ER+ breast cancer.#MBCImpactNJ @komennewjersey Immunotherapy is being combined with CDK4/6 with some success in the lab. Not yet
Read more
Peter Black
pcvblack
Still digesting #bladdercancer trials at #GU21. QUILT 3.032 trial https://clinicaltrials.gov/ct2/show/NCT03022825 testing #N803 in BCG-unresponsive CIS was an important result. Safety data appropriate for intravesical therapy – and CR rat
Read more
‹
1
2
3
4
›
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree